CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
31 research outputs found
Treatment of patients with acute (unstable) symptoms due to coronary artery disease
Author
Campbell
Solomon
+3 more
The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
Theroux
Turpie
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Management of patients with unstable angina/non-ST-elevation myocardial infarction: a critical review of the 2007 ACC/AHA guidelines
Author
Anderson
Antman
+48 more
Antman
Berger
Blazing
Boersma
Braunwald
Cannon
Cannon
Cohen
Cohen
Cohen
de Winter
Eagle
ESPRIT Investigators
Ferguson
Fox
Fox
FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators
Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group
Goodman
Granger
Hirsch
Kastrati
Kastrati
Klein
Lagerqvist
Lagerqvist
Mahaffey
Mak
Mehta
Mehta
Mehta
Mehta
Meine
Montalescot
Morrow
Ndrepepa
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
Silva
Steinhubl
Steinhubl
Stone
The EPIC Investigators
The F.R.A.X.I.S. Study Group
The PURSUIT Trial Investigators
Topol
Waksman
Yusuf
Yusuf
Publication venue
Blackwell Publishing Ltd
Publication date
Field of study
Get PDF
Crossref
PubMed Central
Incorporating platelet glycoprotein iib/iiia inhibition in critical pathways: Unstable angina/non-st-segment elevation myocardial infarction
Author
Anderson
Anderson
+27 more
Antman
Barr
Boden
Cannon
Cannon
Cannon
Cohen
Coller
Hamm
Kong
Lefkovits
Lefkovits
Lincoff
Mark
Stone
The CAPTURE Investigators
The EPIC Investigators
The EPILOG Investigators
The EPISTENT Investigators
The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
The PURSUIT Trial Investigators
The TIMI IIIB Investigators
Topol
Topol
Topol
Van den Brand
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Learning from the Recently Completed Oral Glycoprotein IIb/IIIa Receptor Antagonist Trials
Author
Ault
Cannon
+18 more
Cannon
Cannon
CAPTURE Investigators
Cox
EPIC Investigators
EPILOG Investigators
Holmes
Kong
Langer
Moussa
O'Neill
Peter
The IMPACT-II Investigators
The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
The PURSUIT Trial Investigators
The RESTORE Investigators
The SYMPHONY Investigators
Topol
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Glycoprotein IIb/IIIa inhibitors: More different than alike?
Author
Abdelmeguid
Anderson
+23 more
Brener
Califf
Cannon
Cox
EPISTENT Investigators
IMPACT-II Investigators
Kereiakes
Kereiakes
Lage
Lefkovits
Liu
Mehran
Stone
Tcheng
Tcheng
The CAPTURE Investigators
The EPIC Investigators
The EPILOG Investigators
The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
The PURSUIT Trial Investigators
The RESTORE Investigators
Topol
Willerson
Publication venue
'Wiley'
Publication date
01/01/2001
Field of study
No full text
Crossref
2000 ACC/AHA guidelines for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: A practical summary for emergency physicians
Author
Antman
Antman
+41 more
Antman
Antman
Apple
Apple
Boehrer
Braunwald
Braunwald
Campeau
Cannon
CAPTURE Investigators
Chakko
Charles V. Pollack
Cheitlin
Cohen
Cohen
Cohen
Fesmire
Fesmire
Flores
Fragmin during Instability in Coronary Artery Disease FRISC Study Group
Hoffman
Hyde
Klein
Lange
Lindahl
Maynard
National Center for Health Statistics
Newby
Nouraj
Ohman
Patel
Patel
Pitts
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms PRISM-PLUS Study Investigators
Platelet Receptor Inhibition in Ischemic Syndrome Management PRISM Study Investigators
Selker
Selker
The PURSUIT Trial Investigators
W.Brian Gibler
Weaver
Wu
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Trials of glycoprotein IIb-IIIa inhibitors in non-st-segment elevation acute coronary syndromes: Applicability to the practice of medicine in the united states
Author
Almony
Ambrose
+45 more
Antman
Antman
Armstrong
Cohen
Cohen
Coller
Davies
Deckelbaum
Faulds
Fuster
Gammie
Greenbaum
Hamm
Harrington
Harrington
Heeschen
Kereiakes
Klootwijk
Lefkovits
Lincoff
Lorenz
Mascelli
Mizuno
Ohman
Olatidoye
Oler
Phillips
Simon
Tam
Tcheng
Tcheng
The CAPTURE Investigators
The EPIC Investigators
The EPILOG Investigators
The EPISTENT Investigators
The IMPACT-II Investigators
The PARAGON Investigators
The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
The PURSUIT Trial Investigators
The RESTORE Investigators
Théroux
Wilson
Zhao
Zhao
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Radial versus femoral access for orally anticoagulated patients
Author
Agostoni
Annala
+28 more
Ansell
Ben-Gal
Berry
Bonow
Choussat
Douketis
Doyle
El-Jack
Exaire
Garcia
Helft
Helft
Hildick-Smith
Jessup
Jolly
Karjalainen
Kovacs
Lip
Lo
MacDonald
Martin
Nair
Nikolsky
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
Rubboli
ten Berg
Wazni
Ziakas
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Incidence of high-risk acute coronary syndromes and eligibility for glycoprotein IIb/IIIa inhibitors among patients admitted for possible myocardial ischemia
Author
Antiplatelet Trialists' Collaboration
Antman
+40 more
Antman
Armstrong
Boersma
Braunwald
Braunwald
Fox
Fuster
Fuster
Gibler
Goldman
Goldman
Hamm
Heeschen
James
James L. Tatum
Johnson
Joseph P. Ornato
Karlson
Kong
Kontos
Kontos
Kristin L. Schmidt
Lincoff
Lincoff
Lindahl
Lloyd Jones
Michael C. Kontos
Newby
Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
Polanczyk
PURSUIT Trial Investigators
Robert L. Jesse
Savonitto
Sayre
Scirica
Selker
Tatum
Theroux
Zimmerman
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
The Future of Antiplatelet Therapy: Optimizing Management in Patients with Acute Coronary Syndrome
Author
Aukrust
Berenbaum
+54 more
Berger
Bizzozero
Blann
CAPRIE Steering Committee
EPIC Investigators
EPISTENT Investigators
Folts
Furman
Geiger
Gent
Goodall
Gregorini
Grotemeyer
Harker
Henn
Herbert
Herbert
Holmes
Holmes
Jauhar
Kahn
Kahn
Kastrati
L'Allier
Makkar
Mishkel
Moussa
Neumann
Newby
Nurden
PARAGON Investigators
Peter
Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
Poggio
Quinn
Rupprecht
Schömig
Schömig
Slupsky
Steinhubl
Steinhubl
The CAPTURE Investigators
The IMPACT-II Investigators
The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
The PURSUIT Trial Investigators
The RESTORE Investigators
Topol
Topol
Undas
Urban
Vu
Walter
Weiss
Xu
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
1
2
3
4